Immunohistochemical evaluation is not prognostic for recurrence in fully staged high-risk endometrial cancer
- 1 May 2002
- journal article
- research article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 12 (3) , 286-289
- https://doi.org/10.1046/j.1525-1438.2002.t01-1-01103.x
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- Multidirectional Differentiation of Endometrial Carcinoma with Special Reference to Tumor Aggressiveness Evaluated by Ki-67 ExpressionGynecologic Oncology, 1999
- Lack of bcl-2 Persistence: An Independent Prognostic Indicator of Poor Prognosis in Endometrial CarcinomaGynecologic Oncology, 1998
- Genetic alterations in endometrial carcinomasInternational Journal of Gynecologic Cancer, 1998
- Prospective evaluation of the morbidity of complete lymphadenectomy in endometrial cancerInternational Journal of Gynecologic Cancer, 1998
- Prognostic Significance of Progesterone Receptor Immunohistochemistry in Endometrial CarcinomaGynecologic Oncology, 1998
- Relationship of Nonstaging Pathological Risk Factors to Lymph Node Metastasis and Recurrence in Clinical Stage I Endometrial CarcinomaGynecologic Oncology, 1997
- Angiogenesis in endometrial carcinomaCancer, 1997
- Epithelial and Stromal Estrogen and Progesterone Receptor Expression in Endometrial Cancer: True Color Computer-Assisted Image Analysis versus Subjective ScoringGynecologic Oncology, 1997
- Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group studyGynecologic Oncology, 1991